Ultragenyx Pharmaceutical RARE Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's change in inventories?
- Ultragenyx Pharmaceutical (RARE) reported change in inventories of $4M in Q1 2026.
- How has Ultragenyx Pharmaceutical's change in inventories changed year-over-year?
- Ultragenyx Pharmaceutical's change in inventories increased by 300.0% year-over-year, from $1M to $4M.
- What is the long-term trend for Ultragenyx Pharmaceutical's change in inventories?
- Over 3 years (2021 to 2024), Ultragenyx Pharmaceutical's change in inventories has grown at a 51.5% compound annual growth rate (CAGR), from $3.16M to $11M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.